Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.64 |
| ▸ | CASP6 | P55212 | 2/20 | 0.53 |
| ▸ | G6PD | P11413 | 1/20 | 0.53 |
| ▸ | CASP7 | P55210 | 1/20 | 0.53 |
| ▸ | DNA2 | P51530 | 1/20 | 0.51 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.50 |
| ▸ | CTSD | P07339 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | DTYMK | P23919 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1509448 | 0.98 | TSHR (0.62) | TSHRCASP6G6PDCASP7DNA2 | |
| Hydrochloric Acid SCHEMBL27908306 | 0.98 | TSHR (0.62) | TSHRCASP6G6PDCASP7DNA2 | |
| SCHEMBL28935981 | 0.98 | TSHR (0.62) | TSHRCASP6G6PDCASP7DNA2 | |
| SCHEMBL1509450 | 0.98 | TSHR (0.62) | TSHRCASP6G6PDCASP7DNA2 | |
| SCHEMBL6206355 | 0.89 | TSHR (0.55) | TSHRCASP6DNA2CTDSP1TDP1 | |
| SCHEMBL8411975 | 0.87 | TSHR (0.51) | TSHRCASP6DNA2CTDSP1TDP1 | |
| SCHEMBL631453 | 0.85 | ALDH1A1 (0.57) | TSHRCASP6DNA2CTDSP1TDP1 | |
| SCHEMBL4245567 | 0.85 | TSHR (0.55) | TSHRCASP6G6PDCASP7DNA2 | |
| SCHEMBL1509449 | 0.84 | TSHR (0.49) | TSHRCASP6DNA2CTDSP1TDP1 | |
| SCHEMBL7907999 | 0.84 | CTSD (0.53) | TSHRTDP1CTSDL3MBTL1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 712 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122010739-A | Synthesis method of 2-fluoro-3-nitrobenzoic acid | 山东佰隆医药有限公司 | 2026-05-12 | — | — | CN | claimed |
| CN-115594592-B | Preparation method and application of 2-chloro-3-nitrobenzoic acid | 江西天宇化工有限公司 | 2024-03-19 | — | — | CN | claimed |
| CN-116730871-A | Synthesis method of candesartan intermediate | 湖北郡泰医药化工有限公司 | 2023-09-12 | — | — | CN | claimed |
| CN-115594592-A | Preparation method and application of 2-chloro-3-nitrobenzoic acid | 江西天宇化工有限公司(CN) | 2023-01-13 | — | — | CN | claimed |
| CN-112028811-A | 4-iodo-indole compound and preparation method thereof | 平顶山学院 | 2020-12-04 | — | — | CN | claimed |
| CN-109403101-B | Low-temperature stripping method for dyed fabric | 河南工程学院 | 2020-09-29 | — | — | CN | claimed |
| CN-109281208-B | Low-temperature white discharge printing method for cotton fabric | 河南工程学院 | 2020-09-29 | — | — | CN | claimed |
| CN-109403100-B | Preparation of disperse dye thiourea dioxide low-temperature reduction cleaning catalyst and reduction cleaning method | 河南工程学院 | 2020-09-29 | — | — | CN | claimed |
| CN-109338747-B | Dyeing method for reducing dye thiourea dioxide at low temperature | 河南工程学院 | 2020-09-04 | — | — | CN | claimed |
| CN-109183387-B | Low-temperature neutral reduction bleaching method for protein fiber | 河南工程学院 | 2020-08-21 | — | — | CN | claimed |
| US-7539006-B2 | Electrolytic solution for driving electrolytic capacitor and electrolytic capacitor | RUBYCON CORPORATION (JP) | 2009-05-26 | — | — | US | claimed |
| CN-100456398-C | Electrolyte for driving electrolytic capacitor and electrolytic capacitor | RUBYCON CORP (JP) | 2009-01-28 | — | — | CN | claimed |
| US-20070121276-A1 | Electrolytic solution for use in electrolytic capacitor, and electrolytic capacitor | RUBYCON CORPORATION (JP) | 2007-05-31 | — | — | US | claimed |
| EP-1760737-A1 | ELECTROLYTE FOR DRIVING ELECTROLYTIC CAPACITOR AND ELECTROLYTIC CAPACITOR | Rubycon Corporation (JP) | 2007-03-07 | — | — | EP | claimed |
| US-20070029529-A1 | Electrolytic solution for driving electrolytic capacitor and electrolytic capacitor | KOMATSU AKIHIKO | 2007-02-08 | — | — | US | claimed |
| US-20040245105-A1 | Electrolyte solution for driving electrolytic capacitor and electrolytic capacitor | RUBYCON CORPORATION (JP) | 2004-12-09 | — | — | US | claimed |
| CN-1529892-A | Electrolyte for driving electrolytic capacitor and electrolytic capacitor | 如碧空株式会社 | 2004-09-15 | — | — | CN | claimed |
| EP-1437749-A1 | ELECTROLYTE SOLUTION FOR DRIVING ELECTROLYTIC CAPACITOR AND ELECTROLYTIC CAPACITOR | Rubycon Corporation (JP) | 2004-07-14 | — | — | EP | claimed |
| US-6608193-B2 | Forming an intermediate by reacting the support-bound amino-substituted-tetrahydroisoquinoline compound with a reagent; and cyclizatively cleaving support-bound amino-substituted-tetrahydroisoquinoline compound | THE PROCTER & GAMBLE COMPANY | 2003-08-19 | — | — | US | claimed |
| US-20020077480-A1 | Methods for synthesis of amino-tetrahydroisoquinoline ring compounds | PROCTER & GAMBLE COMPANY, THE | 2002-06-20 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020077480-A1 | Methods for synthesis of amino-tetrahydroisoquinoline ring compounds | ASNS, QPCT, DAO | TSHR 4338/4885CASP6 1437/4885G6PD 2271/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.